Counterintuitively, the AD-risk haplotype [11] is associated with lower levels of SLC41A1 expression, together with PM20D1, which seems to indicate that the epigenetic association with AD and the upregulation of SLC41A1 in AD are the consequence of different mechanisms. Here, SLC41A1 is linked to Alzheimer disease.